ecrin-mdr-crcClinical2013Colorectal CancerColorectal CancerObservationalhttps://newmdr.ecrin.org/Study/2629287Japan12ECRIN MDRRecruitingfalseClinical pharmacology study to evaluate the pharmacokinetics, safety and efficacy of multi-targetted tyrosine kinase inhibitor regorafenib in Japanese patients with advanced colorectal cancer.Primary outcome(s): pharmacokinetics, progression free survival, response rate, adverse event,2013-12-152629287JPRN-UMIN000013939